Hilton Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,220
| Closed | -$336K | – | 137 |
|
|
2025
Q4 | $336K | Hold |
6,220
| – | – | 0.03% | 150 |
|
|
2025
Q3 | $281K | Hold |
6,220
| – | – | 0.02% | 155 |
|
|
2025
Q2 | $288K | Hold |
6,220
| – | – | 0.02% | 158 |
|
|
2025
Q1 | $379K | Hold |
6,220
| – | – | 0.03% | 147 |
|
|
2024
Q4 | $352K | Hold |
6,220
| – | – | 0.03% | 150 |
|
|
2024
Q3 | $322K | Hold |
6,220
| – | – | 0.02% | 154 |
|
|
2024
Q2 | $258K | Hold |
6,220
| – | – | 0.02% | 156 |
|
|
2024
Q1 | $337K | Hold |
6,220
| – | – | 0.03% | 147 |
|
|
2023
Q4 | $319K | Hold |
6,220
| – | – | 0.03% | 138 |
|
|
2023
Q3 | $361K | Hold |
6,220
| – | – | 0.05% | 68 |
|
|
2023
Q2 | $398K | Sell |
6,220
-100
| -2% | -$6.71K | 0.05% | 61 |
|
|
2023
Q1 | $455K | Sell |
6,320
-635
| -9% | -$44.8K | 0.06% | 60 |
|
|
2022
Q4 | $494K | Hold |
6,955
| – | – | 0.07% | 52 |
|
|
2022
Q3 | $494K | Sell |
6,955
-158,148
| -96% | -$11.5M | 0.07% | 52 |
|
|
2022
Q2 | $12.7M | Buy |
165,103
+155,719
| +1,659% | +$11.9M | 1.56% | 17 |
|
|
2022
Q1 | $685K | Buy |
9,384
+1,049
| +13% | +$70.4K | 0.07% | 57 |
|
|
2021
Q4 | $520K | Buy |
8,335
+109
| +1% | +$6.39K | 0.05% | 65 |
|
|
2021
Q3 | $487K | Sell |
8,226
-489
| -6% | -$32.2K | 0.05% | 68 |
|
|
2021
Q2 | $582K | Buy |
8,715
+3
| +0% | +$196 | 0.06% | 66 |
|
|
2021
Q1 | $550K | Buy |
8,712
+260
| +3% | +$16.2K | 0.06% | 62 |
|
|
2020
Q4 | $524K | Sell |
8,452
-146
| -2% | -$8.98K | 0.06% | 58 |
|
|
2020
Q3 | $518K | Buy |
8,598
+162
| +2% | +$9.75K | 0.06% | 56 |
|
|
2020
Q2 | $496K | Sell |
8,436
-416
| -5% | -$24.9K | 0.06% | 56 |
|
|
2020
Q1 | $493K | Buy |
8,852
+74
| +0.8% | +$4.52K | 0.09% | 39 |
|
|
2019
Q4 | $563K | Buy |
8,778
+6,215
| +242% | +$356K | 0.07% | 56 |
|
|
2019
Q3 | $130K | Buy |
2,563
+688
| +37% | +$32.3K | 0.02% | 135 |
|
|
2019
Q2 | $85K | Hold |
1,875
| – | – | 0.01% | 176 |
|
|
2019
Q1 | $89K | Buy |
1,875
+71
| +4% | +$3.54K | 0.01% | 179 |
|
|
2018
Q4 | $94K | Buy |
1,804
+448
| +33% | +$24.1K | 0.02% | 146 |
|
|
2018
Q3 | $84K | Sell |
1,356
-30
| -2% | -$1.78K | 0.01% | 155 |
|
|
2018
Q2 | $77K | Buy |
+1,386
| New | +$74.9K | 0.01% | 181 |
|
Other funds holding BMY
VCM
VPM
Hilton Capital Management's BMY Position: Q1 2026 in Review
Hilton Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 6,220 shares — an estimated $336K sold.
Hilton Capital Management first reported a position in BMY in Q2 2018 and held it in 31 quarters. The position peaked at $12.7M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Hilton Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Hilton Capital Management sold 6,220 Bristol-Myers Squibb shares in Q1 2026, an estimated $336K.
- Hilton Capital Management first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 31 quarters.
- Hilton Capital Management's Bristol-Myers Squibb position peaked at $12.7M in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Hilton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.